Antibody informatics for drug discovery.

Area of Science:

• Biochemistry
• Bioinformatics
• Molecular Engineering

Background:

• The increasing approval of antibody therapeutics highlights their efficacy and specificity.
• Identifying antibody antigens and functions remains a significant challenge in drug discovery.
• Rapid advancements in experimental technologies generate vast antibody data, necessitating robust bioinformatic infrastructure.

Approach:

• This review identifies common obstacles in antibody drug discovery.
• It summarizes progress in antibody informatics, focusing on rational design, data resources, and standardization.
• The article discusses computational approaches for improving antibody affinity and stability, alongside modeling techniques.

Key Points:

• Progress in antibody rational design includes computational methods for affinity and stability enhancement.
• Resources for antibody sequences, structures, immune epitopes, and open drug discovery are vital.
• Standardization through antibody numbering and the IMGT (ImMunoGeneTics) system is essential.

Conclusions:

• Antibody informatics integrates rational design, data resources, and standardization to accelerate antibody drug discovery.
• Bridging industrial needs and academic solutions requires a cohesive bioinformatic approach.
• This field is critical for advancing molecular engineering of antibodies.